Navidea Biopharmaceuticals, Inc. (NAVB) Share

Navidea Biopharmaceuticals, Inc. is a United States-based company operating in the biopharmaceutical sector. The company focuses on the development and commercialization of precision diagnostic radiopharmaceuticals and therapeutics. Its primary focus is on advancing targeted diagnostic and therapeutic agents for use in nuclear medicine imaging and therapy. Navidea's research and development efforts are geared towards addressing unmet medical needs in areas such as autoimmune diseases, cancer, and other inflammatory conditions. By creating innovative imaging agents, Navidea aims to provide clinicians with tools for earlier and more accurate diagnosis, potentially leading to improved patient outcomes. The company trades on the OTC market, providing investors with an opportunity to participate in the growth of a biopharmaceutical company dedicated to advancing precision medicine.